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Aims
A trial-based comparison of the use of resources, costs and quality of life outcomes of 
arthroscopic and open surgical management for rotator cuff tears in the United Kingdom 
NHS was performed using data from the United Kingdom Rotator Cuff Study (UKUFF) 
randomised controlled trial.
Patients and Methods
Using data from 273 patients, healthcare-related use of resources, costs and quality-
adjusted life years (QALYs) were estimated at 12 months and 24 months after surgery on an 
intention-to-treat basis with adjustment for covariates. Uncertainty about the incremental 
cost-effectiveness ratio for arthroscopic versus open management at 24 months of follow-
up was incorporated using bootstrapping. Multiple imputation methods were used to deal 
with missing data.
Results
There were no significant differences between the arthroscopic and open groups in terms of 
total mean use and cost of resources or QALYs at any time post-operatively. Open 
management dominated arthroscopic management in 59.8% of bootstrapped cost and 
effect differences. The probability that arthroscopic management was cost-effective 
compared with open management at a willingness-to-pay threshold of £20 000 per QALY 
gained was 20.9%.
Conclusion
There was no significant overall difference in the use or cost of resources or quality of life 
between arthroscopic and open management in the trial. There was uncertainty about 
which strategy was most cost-effective.
Cite this article: Bone Joint J 2016;98-B:1648–55.
Rotator cuff abnormalities (including degener-
ative tears and those due to injury) reportedly
account for up to 70% of symptoms associated
with the shoulder1 and have significant effects
on quality of life and activities of daily living.2
Various forms of treatment are available for
the symptomatic rotator cuff tear. Conserva-
tive management includes combinations of
rest, exercise, physiotherapy, and pain relief.
Surgery may also be undertaken to repair the
tear using either an arthroscopic or open
(including “mini-open”) technique. Recent
studies have shown that the number of rotator
cuff procedures is increasing, in part due to a
preference for minimally invasive tech-
niques.3,4 However, little is known about the
relative costs and health-related quality of life
outcomes of arthroscopic and open procedures
to help justify the choice of surgery in the
United Kingdom. Existing studies reporting
the costs of rotator cuff repair to the NHS, are
non-randomised, based on a small number of
patients, and do not incorporate both eco-
nomic and health-related quality of life out-
comes.5,6
The United Kingdom Rotator Cuff Study
(UKUFF) was a randomised controlled trial,
carried out to investigate the clinical and cost
outcomes of arthroscopic and open procedures
in patients with degenerative full-thickness
rotator cuff tears over a period of 24 months
after surgery. Full details of the study are
described elsewhere (trial registration number
ISRCTN 97804283, UK Multi-centre
Research Ethics Committee approved, ref: 10/
H0402/24).7,8 On an intention-to-treat (ITT)
basis there was no statistical difference
between the arthroscopic and open groups; the
difference in Oxford Shoulder Score (OSS)9 at
24 months was 0.76 (95% confidence interval
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(CI) -1.22 to 2.75; p = 0.452) favouring open management.
There was no clinically important difference between the
groups at 24 months, based on a predetermined difference
in OSS of three points.7
The objective of this further study was to compare the
use of resources, costs and health-related quality of life out-
comes associated with arthroscopic and open surgical man-
agement of rotator cuff tears using two-year follow-up data
from 273 randomised patients in the UKUFF trial. As far as
we are aware, this is the first formal economic comparison
of arthroscopic and open rotator cuff repair to be under-
taken in the United Kingdom NHS which incorporates both
cost and quality of life outcomes, and the first study to esti-
mate NHS costs for rotator cuff repair using data from a
randomised controlled trial.
Patients and Methods
We compared health-related quality of life, the use of
resources, healthcare costs and cost-effectiveness of arthro-
scopic management with that of open repair for full thick-
ness rotator cuff tears using data from the UKUFF trial. We
used individual data from Stratum A of the study, which
consisted of a randomised comparison of arthroscopic and
open management. 
Between November 2007 and February 2012 a total of
136 patients were allocated (using minimisation according
to surgeon, age and size of tear) to arthroscopic and 137 to
open surgery in 19 centres in the United Kingdom. After
randomisation, the specifics of the procedures were subse-
quently the choice of the surgeon.7,8 The inclusion and
exclusion criteria for the original study are shown in Table
I. There were 81 (60%) men in the arthroscopic group and
88 (64%) in the open group. The mean age was 62.9 years
in both groups (standard deviation (SD) 7.1 for arthro-
scopic and 7.5 for open management). 
The primary outcome of the economic analysis was the
incremental cost per quality-adjusted life year gained with
arthroscopic compared with open repair, using an ITT
approach. The online supplementary material includes
results using a per-protocol approach (i.e. including only
the subset of patients who received their allocated interven-
tion). The perspective was that of the healthcare system (the
United Kingdom NHS), and the time horizon was the dura-
tion of the UKUFF trial (up to 24 months post-operatively),
with longer-term extrapolation if clear evidence was found
of differences in costs or effects. Analyses were conducted
using Stata/SE 12 software (StataCorp. LP, College Station,
Texas).
Outcomes were compared by ITT, defined as the
intended procedure (arthroscopic or open) before surgery
commenced. The use of resources relating to the initial pro-
cedure, specifically the time in theatre and the number and
type of bone anchors, was recorded for each patient by
healthcare staff in the operating theatre on a paper-based
form. Information on additional equipment used during
surgery was obtained via observation, and incorporated as
a fixed cost of consumables for each type of procedure. Fur-
ther details are given in Table II.10-12 Data for the individual
patients were not collected for revision surgery, so the costs
of the procedure for these were assumed to be equal to the
mean cost of the initial procedure by type. The length of
stay in hospital was estimated using the date of surgery and
the date of discharge as reported on questionnaires given to
the patients two or eight weeks post-operatively.
Data for the use of resources after discharge were col-
lected using questionnaires returned at 12 months and 24
months post-operatively. Items included further surgery,
such as revision surgery or the treatment of infected
wounds; number of inpatient and outpatient visits, and
appointments with a GP, nurse, or physiotherapist. Use of
prescribed medications such as painkillers was recorded on
the questionnaires at two and eight weeks post-operatively.
For the analysis, we assumed that the use reported in the
questionnaires was the daily dose throughout the period
covered by the questionnaire.
Total costs were calculated by applying unit costs for the
2012 to 2013 cost year obtained from manufacturers and
national cost estimates (Table II) to the resource use infor-
mation obtained from the questionnaires. For surgical
equipment, an assumed 30% price discount was applied to
list prices obtained from manufacturers (Table II), to repre-
sent the estimated price paid by the hospitals.
Health-related quality of life was measured using the
responses to the EuroQol (EQ)-5D-3L instrument,13
obtained from questionnaires returned at baseline and at
eight, 12 and 24 months post-operatively. Using Stata com-
mand ‘eq5d’ the EQ-5D-3L responses for each patient at
each time point were converted to quality of life valuations,
where ‘1’ represents full health and ‘0’ represents death
(negative valuations are possible but were none were
Table I. The inclusion and exclusion criteria for the United Kingdom Rotator Cuff Study
Inclusion criteria Exclusion criteria
The patient must satisfy all the following criteria to be eligible for the study: The patient may not enter the study if ANY of the following apply:
-Aged over 50 years -Previous surgery on the affected shoulder
-Suffer from a degenerative rotator cuff tear -Dual shoulder pathology
-Have a full thickness rotator cuff tear -Significant problems in the other shoulder
-Rotator cuff tear diagnosed using MRI or ultrasound scan -Rheumatoid arthritis/systemic disease
-Patient able to consent -Significant osteoarthritis problems
-Significant neck problems
-Cognitive impairment or language issues
-Unable to undergo an MRI scan for any reason
1650 J. MURPHY, A. GRAY, C. COOPER, D. COOPER, C. RAMSAY, A. CARR
THE BONE & JOINT JOURNAL
observed in this study), using the United Kingdom popula-
tion tariff.14,15 Total quality-adjusted life years (QALYs)
were calculated for each patient using an area under the
curve (AUC) approach after linear interpolation between
time points.
Imputation via chained equations (with the ‘mi impute
chained’ command in Stata) was used to impute missing
data for initial hospitalisation, use and cost of resources
during follow-up, and EQ-5D-3L domains in the original
data set.16 In total, 30 complete data sets were produced
(equal to the highest percentage of missing data in any of
the variables to be imputed)17 and subsequently combined
using Rubin’s rules via the ‘mi estimate’ command in Stata,
to account for variation both within and between data
sets.16
Cost and quality of life outcomes accrued after 12
months of follow-up were time-discounted at a rate of
3.5% per year, as currently recommended.18
A cost-utility analysis was performed using the total
costs and QALYs at 24 months of follow-up for those ran-
Table II. Unit costs
Cost category Unit cost (£ 2012/13) Source and description
Surgery costs (all participants)*
Cost per minute in theatre 16.43 Mean cost per minute in orthopaedic operating theatre. Average over 15 NHS 
boards in Scotland, year end March 2013. Information Services Division Scot-
land release 17 December 2013.10
Cost per anchor
Open repair 103.67 Manufacturer’s list price with a price discount applied. Costs presented are the 
mean anchor cost for participants receiving each type of surgery. The list 
prices (without price discount) for the anchors ranged from £141 to £262. Illus-
trative average anchor cost here is based on mean total anchor cost divided by 
mean number of anchors (using imputed data).
Arthroscopic repair 107.43
Other procedures 98.52
Additional fixed surgical costs
Average cost per suture 7.14 Average of manufacturer’s list prices (with price discount)† for each suture type 
recorded on theatre forms.
Drapes‡ 16.41 Manufacturer’s list prices (with price discount)† for shoulder arthroscopy drape 
and video camera drape.
Fluid management system one day tubing‡ 20.30 Manufacturer’s list price (with price discount).†
90º suction electrode§ 90.00 Hospital cost obtained (with price discount).†
5.5 mm full radius resector¶ 57.51 Manufacturer’s list price (with price discount).†
4.0 mm oval burr¶ 57.51 Manufacturer’s list price (with price discount)†
Monopolar diathermy electrosurgical 
single-use pencil**
1.93 Manufacturer’s list price (with price discount).†
Arthroscopic suture needle†† 157.14 Cost obtained from supplier to the Nuffield Orthopaedic Centre, Oxford (with 
price discount).†
Post-surgery and follow-up costs*
Cost per inpatient bed day 378.93 Elective inpatient excess bed day from NHS reference costs. Weighted average 
of all Shoulder and Upper Arm Procedures for Non-Trauma “Trauma & Ortho-
paedics”. From 2012 to 2013 NHS reference cost data file “The main schedule”, 
“El_XS” tab.11
Surgery during follow-up
Repair (open) 1977.68 All repair costs were calculated using the average cost for each type of proce-
dure within the trial (cost of time in theatre, anchors, and fixed equipment 
costs). The costs of nights in hospital relating to surgery during follow-up were 
incorporated separately.
Repair (arthroscopic) 2192.80
Repair (unknown type) 2085.24
Reverse shoulder replacement 3722.11 Elective inpatient excess bed day from NHS reference costs. Weighted average 
inpatient cost for major shoulder and upper arm procedures with/without com-
plications, non-trauma, “Trauma and Orthopaedics”. From 2012 to 2013 NHS 
reference cost data file “The main schedule”, “El” tab.11
Washout procedure 337.48 Elective inpatient excess bed day from NHS reference costs. Weighted average 
of minor and intermediate shoulder and upper arm procedures for non-
trauma. From 2012 to 2013 NHS reference cost data file “The main schedule”, 
“El_XS” tab.11
Cost per appointment with GP 37.00 Consultation lasting 11.7 minutes, including direct care staff costs, excluding 
qualification costs. Personal Social Services Research Unit (PSSRU) costs of 
health and social care 2013, table 10.8b.12
Cost per appointment with nurse 11.34 Based on a 15.5 minute face-to-face consultation. PSSRU costs of health and 
social care 2013, table 10.6.12
Cost per session with physiotherapist 43.69 Weighted average of NHS own costs for hospital and community based 
appointments. From 2012 to 2013 NHS reference cost data file “The main 
schedule”, “NCL” and “CHSAHP” tabs.11
Outpatient visits (shoulder) 162.08 Weighted average outpatient cost for major, intermediate, and minor outpa-
tient procedures (OPROC tab).11
* applied to all participants according to resource use for each participant
† an assumed price discount of 30% has been applied to the list prices to produce the cost to the hospital (as shown) for surgical items
‡ all procedures
§ mini-open repair, arthroscopic repair, all sub-acromial decompression (SAD), biceps tenotomy, and capsular release procedures
¶ mini-open repair, arthroscopic repair, and all SAD procedures
** open repair, mini-open repair, and open partial-thickness tear procedures 
†† arthroscopic procedures only
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domised to arthroscopic or open repair. The incremental
cost-effectiveness ratio (ICER) was calculated as the incre-
mental cost per QALY gained for arthroscopic compared
with open surgery over a 24-month follow-up. Uncertainty
about the ICER was characterised using non-parametric
bootstrapping19 by sampling 1000 bootstrap replicates of
the mean total cost and mean total effect differences
between the two groups. The bootstrapped pairs of cost
and effect differences were plotted on the cost-effectiveness
plane to illustrate the uncertainty around the point estimate
for the ICER, and a cost-effectiveness acceptability curve
was produced to illustrate the probability of arthroscopic
surgery being cost-effective compared with open surgery at
a range of willingness to pay thresholds.
All results are presented on an ITT basis using imputed
data, and for the base case mean differences were adjusted
for age, centre, and the size of the tear at baseline. Mean
differences in quality of life outcomes were also adjusted
for EQ-5D levels at baseline.20 Unadjusted mean differ-
ences are also presented.
Results
Of the 273 patients in this study, 136 were randomised to
arthroscopic management. In this group, 63 (46%) had an
arthroscopic repair for a tear, 28 (21%) had an arthro-
scopic procedure not including a repair, such as a sub-
acromial decompression (SAD), nine (7%) arthroscopic
repairs were converted to an open repair during the proce-
dure, and 36 patients (26%) withdrew before surgery. Of
the 137 patients randomised to open management, 85
(62%) had an open repair for a tear, 24 (18%) had an
arthroscopic procedure not including a repair, such as a
SAD, five (4%) had an arthroscopic repair instead, and 23
(17%) withdrew before surgery.7
The rate of response to the questionnaires was 100% at
baseline, 90% at 12 months and 86% at 24 months follow-
up. However, the number of patients with complete data
for theatre time, anchors, equipment and length of stay was
lower at 85 (63%) at discharge for those randomised to
arthroscopic repair and 94 (69%) for those randomised to
open repair. At 12 months post-operatively, the number of
patients with complete data (for discharge, revision surgery,
use of healthcare resources, out-of-pocket costs, and EQ-
5D domains) was 44 (32%) for the arthroscopic group and
60 (44%) for the open group. At 24 months, this was 39
(29%) for the arthroscopic group and 57 (42%) for the
open group. The number of deaths during the 24 month
period was three: two in the arthroscopic group, and one in
the open group. None were related to participation in the
study.
The use and costs of resources relating to initial procedures. The
use and costs of resources relating to initial procedures are
shown in Table III. Both theatre time and the cost of theatre
time were slightly higher for arthroscopic than for open
management, but this was not statistically significant. The
mean time in theatre was 71.0 minutes (standard error of
the mean (SEM) 4.9) for those in the arthroscopic group,
corresponding to a mean cost of £1166 (SEM 80). For those
in the open management group, the mean time in theatre
was 71.1 minutes (SEM 3.6) minutes, with a mean cost of
£1169 (SEM 60). 
Both the number and type (i.e. brand) of anchors were
identified from the theatre records and used to incorporate
the costs of anchors on an individual patient basis. The mean
number of anchors used was 1.2 (SEM 0.1) for the arthro-
scopic group, with a mean cost of £127 (SEM 14). For the
open group the mean number of anchors was 1.4 (SEM 0.1)
with a mean cost of £147 (SEM 14). There was no statistically
significant difference in either the number of anchors or their
cost in each group. However the mean difference in other
equipment costs (not including anchors) was statistically sig-
nificant, at £77 (95% confidence interval (CI) 56 to 97) more
for arthroscopic than for open management.
The mean total cost of the initial procedure, incorporat-
ing time in theatre, anchors, and other equipment costs but
excluding length of stay, was £1497 (SEM 96) for arthro-
scopic and £1460 (SEM 71) for open management. This cost
was significantly greater for arthroscopic management with
a mean of £187 (95% CI 35 to 339) more costly than open
management.
Overall the total mean procedure-related cost (including
the costs of surgery and length of stay) was £1701
(SEM 115) for arthroscopic and £1715 (SEM 86) for open
management, however this was not statistically significant.
Table III. Resource use and cost outcomes relating to initial procedure by intention-to-treat using imputed data
Mean 
resource use
Arthroscopic 
(n = 136) 
mean (SEM)
Open (n = 137) 
mean (SEM)
Arthroscopic vs 
open mean difference 
(CI; p-value) 
(no covariate 
adjustment)
Arthroscopic vs open 
mean difference (CI;
p-value) (adjusting for 
age, tear size, centre)
Arthroscopic 
(n = 136) mean 
cost, £ (SEM)
Open (n = 137) 
mean cost, £ 
(SEM)
Arthroscopic vs open 
mean cost difference 
(CI; p-value) (base case, 
no covariate adjustment)
Arthroscopic vs open 
mean cost difference, 
£ (CI; p-value) (adjusting 
for age, tear size, centre)
Theatre time 71.0 (4.9) 71.1 (3.6) -0.2 (-12.1 to 11.8; 0.981) 6.8 (-1.3 to 14.9; 0.102) 1166 (80) 1169 (60) -2 (-199 to 194; 0.981) 111 (-22 to 244; 0.102)
Anchors 1.2 (0.1) 1.4 (0.1) -0.2 (-0.5 to 0.2; 0.352) 0.0 (-0.3 to 0.3; 0.889) 127 (14) 147 (14) -20 (-56 to 17; 0.288) -1 (-29 to 28; 0.959)
Equipment - - - - 202 (12) 145 (7) 58 (31 to 84; 0.000) 77 (56 to 97; 0.000)
Total cost of 
surgery
- - - - 1497 (96) 1460 (71) 36 (-200 to 271; 0.766) 187 (35 to 339; 0.016)
Nights in 
hospital
0.5 (0.1) 0.7 (0.1) -0.1 (-0.4 to 0.2; 0.399) -0.1 (-0.4 to 0.2; 0.578) 206 (46) 255 (36) -49 (-165 to 66; 0.399) -32 (-147 to 82; 0.578)
Total 
procedure-
related costs 
- - - - 1701 (115) 1715 (86) -14 (-297 to 270; 0.924) 155 (-45 to 354; 0.129)
SEM, standard error of the mean; CI, confidence interval
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The use and costs of resources at 12 months of follow-up. The
use and costs of resources at 12 months of follow-up are
shown in Table IV.
No patients in the arthroscopic group underwent revi-
sion surgery, that is, a repeat repair or a washout, during
the first 12 months of follow-up. The mean cost per person
of revision surgery for the open group was £2 (SEM 2).
There were no significant differences between the two groups
in the number or cost of healthcare appointments, hospital visits
and medications during the first 12 months of follow-up.
The mean total cost during the first 12 months of follow-
up was £694 (SEM 66) for the arthroscopic group and £881
(SEM 93) for the open group. This difference was not statis-
tically significant.
The use and cost of resources at 24 months of follow-up. The
rate of revision surgery between 12 and 24 months of fol-
low-up was low, with a mean cost per patient of £30 (SEM
21) for arthroscopic and £31 (SEM 22) for open manage-
ment. The mean difference was not statistically significant.
Similarly, there were no statistically significant differences
between the two groups in the number or cost of healthcare
appointments and hospital visits between 12 and 24
months of follow-up. After adjusting for covariates, these
differences remained non-significant.
The total mean cost after time-discounting, including initial
surgery up to 24 months of follow-up, was £2567 (SEM 176)
for arthroscopic and £2699 (SEM 149) for open management,
however this difference was not statistically significant.
Quality of life outcomes. Quality of life outcomes using
the imputed data are presented in Table V. Substantial
improvements were seen in both groups. In the arthro-
scopic group, the mean EQ-5D improved from 0.55 (SEM
0.03) at baseline to 0.74 (SEM 0.02) 24 months post-opera-
tively. Similarly, in the open management group, the mean
EQ-5D improved from 0.52 (SEM 0.02) at baseline to 0.76
(SEM 0.02) at 24 months. The difference in mean EQ-5D
between the two groups was not statistically significant at
any follow-up point.
The overall mean total QALYs over the 24 month period
were 1.34 (SEM 0.04) for arthroscopic, and 1.35 (SEM 0.04)
for open management, after time-discounting. The mean
difference (95% CI) in total QALYs over the 24 month
period of study was not statistically significant after adjust-
ing for covariates.
Incremental cost-effectiveness. The results of the incremen-
tal analysis are shown in Table VI. Arthroscopic manage-
ment was slightly more costly and less effective than open
management although the differences were not statistically
significant.
Modelling the joint distribution of uncertainty around
the cost and effect differences using bootstrapping and
adjusting for covariates, there was an estimated 59.8%
probability that open management dominates arthroscopic
management (that it is less costly and more effective), with
a point-estimate in the north-west quadrant of the cost-
effectiveness plane. However, there is substantial uncer-
tainty around this ICER (Fig. 1).
At a threshold of £20 000 per QALY gained (in line with
the generally accepted lower limit of the threshold in the
United Kingdom),18 there is a 20.9% probability that
 Table IV. The use and cost of resources and outcomes for follow-up by intention-to-treat using imputed data
Mean resource use
Arthroscopic 
(n = 136) mean 
(SEM)
Open (n = 137) 
mean (SEM)
Arthroscopic vs open mean 
difference (CI; p-value) (no 
covariate adjustment)
Arthroscopic vs open mean 
difference (CI; p-value) 
(adjusting for age, tear size, 
centre)
Arthroscopic 
(n = 136) 
mean cost, 
£ (SEM)
Open (n = 137) 
mean cost, 
£ (SEM)
Arthroscopic vs open mean 
cost difference, £ (CI; p-value) 
(no covariate adjustment)
Arthroscopic vs open 
mean cost difference, 
£ (CI; p-value) (adjusting 
for age, tear size, centre)
Revision procedures between 
surgery and 12 mths
0 (-) 0.0 (0.0) -0.01 (-0.02 to 0.01; 0.320) -0.01 (-0.02 to 0.01; 0.339) 0 (-) 2 (2) -2 (-7 to 2; 0.320) -2 (-7 to 3; 0.339)
GP visits between surgery and 
12 mths
1.1 (0.2) 1.2 (0.2) -0.1 (-0.6 to 0.5; 0.831) 0.0 (-0.6 to 0.5; 0.948) 40 (7) 43 (6) -2 (-22 to 18; 0.831) -1 (-21 to 19; 0.948)
Nurse visits between surgery 
and 12 mths
0.3 (0.1) 0.5 (0.1) -0.2 (-0.5 to 0.1; 0.256) -0.2 (-0.5 to 0.2; 0.354) 4 (1) 6 (2) -2 (-6 to 2; 0.256) -2 (-6 to 2; 0.354)
Physiotherapist visits between 
surgery and 12 mths
6.1 (0.6) 6.3 (0.5) -0.2 (-1.7 to 1.4; 0.818) 0.3 (-1.1 to 1.7; 0.685) 267 (24) 275 (24) -8 (-75 to 59; 0.818) 13 (-49 to 74; 0.685)
Inpatient visits between surgery 
and 12 mths
0.3 (0.1) 0.4 (0.1) -0.1 (-0.5 to 0.2; 0.418) -0.1 (-0.5 to 0.2; 0.485) 119 (37) 170 (51) -52 (-178 to 74; 0.418) -45 (-173 to 83; 0.485)
Outpatient visits between 
surgery and 12 mths
1.6 (0.2) 2.3 (0.3) -0.7 (-1.5 to 0.0 ; 0.045) -0.6 (-1.3 to 0.2; 0.134) 259 (31) 380 (52) -121 (-240 to -2; 0.045) -92 (-213 to 29; 0.134)
Medication costs between 
surgery and 12 mths
- - - - 6 (1) 4 (1) 1 (-2 to 5; 0.386) 2 (-2 to 5; 0.336)
Cost after surgery to 12 mth 
follow-up
- - - - 694 (66) 881 (93) -187 (-413 to 40; 0.106) -128 (-350 to 94; 0.256)
Total costs up to 12 mths - - - - 2395 (149) 2596 (142) -200 (-607 to 207; 0.333) 26 (-283 to 337; 0.867)
Revision procedures between 
12 and 24 mths
0.01 (0.01) 0.02 (0.01) -0.01 (-0.04 to 0.02; 0.659) 0.00 (-0.04 to 0.03; 0.768) 30 (21) 31 (22) -1 (-60 to 59; 0.986) 4 (-58 to 66; 0.899)
GP visits between 12 and 
24 mths
0.4 (0.1) 0.4 (0.1) 0.1 (-0.2 to 0.4; 0.597) 0.1 (-0.2 to 0.4; 0.600) 17 (5) 13 (4) 3 (-9 to 15; 0.597) 3 (-9 to 16; 0.600)
Nurse visits between 12 and 
24 mths
0.1 (0.1) 0.1 (0.0) 0.0 (-0.1 to 0.2; 0.750) 0.0 (-0.1 to 0.1; 0.819) 1 (1) 1 (0) 0 (-1 to 2; 0.750) 0 (-1 to 2; 0.819)
Physiotherapist visits between 
12 and 24 mths
1.2 (0.5) 0.5 (0.2) 0.7 (-0.3 to 1.7; 0.196) 0.7 (-0.3 to 1.7; 0.160) 51 (21) 23 (8) 29 (-15 to 72; 0.196) 31 (-12 to 75; 0.160)
Inpatient visits between 12 and 
24 mths
0.03 (0.02) 0.00 (0.00) 0.03 (–0.02 to 0.08) 0.03 (–0.02 to 0.08) 12 (9) 0 (-) 11 (-6 to 29; 0.209) 12 (-6 to 30; 0.198)
Outpatient visits between 
12 and 24 mths
0.4 (0.1) 0.2 (0.1) 0.2 (-0.1 to 0.5; 0.282) 0.2 (-0.1 to 0.5; 0.212) 67 (23) 39 (12) 27 (-23 to 77; 0.282) 31 (-18 to 80; 0.212)
Total cost from 12 to 24 mths - - - - 177 (59) 107 (30) 70 (-59 to 200; 0.268) 82 (-49 to212; 0.219)
Total cost over 24 mths - - - - 2573 (177) 2703 (150) -130 (-589 to 329; 0.578) 108 (-255 to 471; 0.558)
Total cost over 24 mths
(time-discounted)
- - - - 2567 (176) 2699 (149) -132 (-589 to 324; 0.569) 105 (-255 to 466; 0.565)
SEM, standard error of the mean; CI, confidence interval
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arthroscopic management was cost-effective (more costly
but more effective) compared with open management, and
therefore a 79.1% probability that open management was
cost-effective at the same threshold (Fig. 2).
Discussion
We found that the mean cost of the procedure was signifi-
cantly greater (£187, 95% CI 35 to 339) for arthroscopic
than for open management, after adjustment for covariates.
However, when incorporating the cost of nights in hospital,
the overall cost related to the initial procedure was margin-
ally (but not significantly) greater for open management.
We found no significant differences between arthro-
scopic and open management in the number of healthcare
appointments and hospital stays at surgery and at 12 or 24
months follow-up, either before or after adjustment of
Table V. Quality of life outcomes: quality-adjusted life years (QALYs) by intention-to-treat using imputed data
Arthroscopic (n = 136) 
mean QALYs (SEM)
Open (n = 137) 
mean QALYs (SEM)
Arthroscopic vs open mean 
difference in QALYs (CI; p-value) 
(no covariate adjustment)
Arthroscopic vs open mean 
difference in QALYs (CI; p-value) 
(adjusting for baseline EQ-5D, 
age, tear size, centre)
Quality of life
EQ-5D_index_BL 0.55 (0.03) 0.52 (0.02) 0.03 (-0.04 to 0.10; 0.352) 0.03 (-0.04 to 0.11; 0.336)*
EQ-5D_index_8mo 0.68 (0.03) 0.69 (0.02) -0.01 (-0.08 to 0.05; 0.691) -0.03 (-0.09 to 0.04; 0.392)
EQ-5D_index_12mo 0.72 (0.02) 0.71 (0.03) 0.01 (-0.06 to 0.08; 0.852) -0.01 (-0.08 to 0.06; 0.788)
EQ-5D_index_24mo 0.74 (0.02) 0.76 (0.02) -0.03 (-0.09 to 0.03; 0.389) -0.04 (-0.10 to 0.02; 0. 232)
Quality-adjusted life years
QALYs from baseline to 8 mths 0.41 (0.01) 0.40 (0.01) 0.01 (-0.03 to 0.05; 0.740) -0.01 (-0.03 to 0.01; 0.392)
QALYs from 8 mths to 12 mths 0.23 (0.01) 0.23 (0.01) -0.00 (-0.02 to 0.02; 0.911) -0.01 (-0.03 to 0.01; 0.529)
QALYs from 12 mths to 24 mths 0.73 (0.02) 0.74 (0.02) -0.01 (-0.07 to 0.05; 0.734) -0.02 (-0.08 to 0.03; 0.414)
TOTAL QALYs over 24 mths 1.37 (0.04) 1.37 (0.04) 0.00 (-0.11 to 0.10; 0.931) -0.04 (-0.12 to 0.05; 0.392)
TOTAL QALYs over 24 mths 
(time-discounted)
1.34 (0.04) 1.35 (0.04) 0.00 (-0.11 to 0.10; 0.935) -0.04 (-0.12 to 0.05; 0.392)
All outcomes use imputed data
* not adjusted for baseline EQ-5D (EQ-5D_index_BL), only for age, tear size and centre
EQ-5D, EuroQol-5D; SEM, standard error; CI, confidence interval
Table VI. Incremental analysis by intention-to-treat using imputed data
Total costs (time-discounted)* Total QALYs over 24 mths 
(time-discounted)*
ICER (quadrant)†Probability (%)§ that arthroscopic repair is: 
Adjustment 
for covariates
Arthro-
scopic mean 
cost, £ (SEM)
Open 
mean 
cost, 
£ (SEM)
Difference 
(adjusted for 
covariates), 
£ (CI; p-value) Arthroscopic Open
Difference 
(adjusted for 
covariates), £ (CI; 
p-value)
Mean incremen-
tal cost per 
QALY gained, £
More 
effective
Less 
costly Dominant Dominated
Cost-effective 
at £20 000 per 
QALY gained
Adjusted 
(base case)‡
2567 (176) 2699 (149)105 (-255 to 466; 
p = 0.565)
Mean (SEM) 
1.34 (0.04)
Mean (SEM) 
1.35 (0.04)
-0.04 (-0.12 to 0.05; 
p = 0.392)
Dominated by 
open (-£2845 
(north-west 
quadrant of CE 
plane)
23.0 26.6 9.4 59.8 20.9
Unadjusted 2567 (176) 2699 (149)-132 (-589 to 324; 
p = 0.569)
1.34 (0.04) 1.35 (0.04) 0.00 (-0.11 to 0.10; 
p = 0.935)
£30 001 (south-
west quadrant of 
CE plane)
47.5 74.4 37.5 15.6 53.7
* uncertainty around costs and effects was calculated parametrically
† uncertainty around the ICER was estimated using 1000 bootstrap replicates of final merged data set after multiple imputation 
‡ covariates: EuroQol-5D at baseline (for QALY outcomes only), age, tear size, centre 
§ out of 1000 replicates
QALY, quality-adjusted life years; ICER, incremental cost per quality-adjusted life year gained; SEM, standard error of the mean; CI, confidence interval; CE, cost-effectiveness
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Fig. 1a
Cost-effectiveness planes for a) arthroscopic versus open management by intention-to-treat, adjusted for covariates and b) arthroscopic versus open
management by intention-to-treat, no adjustment for covariates.
Fig. 1b
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covariates. The total mean cost at 12 months was higher
(but not significantly so) for open management before
adjustment, however after adjustment the cost was margin-
ally (but again, not significantly) higher for arthroscopic
management. Similarly, the total overall cost at 24 months
was higher (but not significantly so) for open management
before adjustment, but after adjustment it was (non-
significantly) higher for arthroscopic management.
There was no significant difference between groups, in
either the unadjusted or adjusted analyses, in the mean total
cost at initial hospitalisation and 12- or 24-month follow-
up, despite a significantly higher cost of the procedure in
the arthroscopic group. There was also no significant dif-
ference in mean total QALYs between the two groups at
any time point. Consequently, extrapolating the results
beyond the study period would have served no purpose.
The point estimate of the ICER suggested that arthro-
scopic management was dominated by open management
(implying that arthroscopic management is more costly and
associated with fewer total QALYs at 24 months). As for
the cost and quality of life results, there was considerable
uncertainty around this ICER. Arthroscopic management
was dominated by open management in 59.8% of the boot-
strapped cost and effect differences. Conversely, there was a
20.9% probability that arthroscopic management was
cost-effective compared with open management at a thresh-
old of £20 000. Therefore the CIs around the differences in
cost and effect between the groups are also reflected in the
uncertainty around the ICER, supporting the conclusion
that there was no clear difference between the two forms of
management in the trial.
Our study was designed prospectively and conducted
alongside a national randomised trial involving many cen-
tres. It had some limitations. Assumptions had to be made
about the price discounts offered to hospitals for anchors
and other consumables. Detailed information was not col-
lected on resources used during re-admissions involving
surgical procedures, although the procedures themselves
were fully documented and were few in number. We believe
that the trial fairly reflects the provision of these procedures
in the real world, but it should be borne in mind that only
63 (46%) of those randomised to arthroscopic manage-
ment and 85 (62%) of those randomised to open manage-
ment actually received the intended procedure; our results
should therefore be interpreted as an ITT comparison. The
analysis was conducted from the perspective of the health-
care system and did not incorporate societal costs such as
time off work.
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Fig. 2a
Cost-effectiveness acceptability curves for a) arthroscopicversus open management by
intention-to-treat, adjusted for covariates and b) arthroscopic versus open management
by intention-to-treat, no adjustment for covariates.
Fig. 2b
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In a recent paper, Judge et al3 found that the number of
subacromial decompression and rotator cuff repair proce-
dures being performed in England grew rapidly from 1.4
per 100 000 population in 2004/05, to 13.7 per 100 000 in
2009/10, and suggested that one reason for this may be a
growing preference for less invasive arthroscopic tech-
niques. A recent study in the United States showed that the
volume of rotator cuff repairs increased by 141% over a
ten-year period from 1996 to 2006.4 During this time the
number of open repairs increased by 34%, while the num-
ber of arthroscopic repairs increased by 600%. Although it
is commonly believed that less invasive techniques are asso-
ciated with shorter periods of recovery and better out-
comes, the evidence is conflicting.21-25 In addition, existing
evidence on the comparative costs of the procedures to the
NHS is limited to small, non-randomised studies.5,6
In this study, we found that the arthroscopic procedure
took slightly longer to perform but on an ITT basis this dif-
ference was not statistically significant. We found that the
cost of the procedure was significantly greater for arthro-
scopic than for open repair, after adjusting for age, centre
and the size of the tear, but that there was no significant dif-
ference in overall costs between the two procedures, and we
found no discernible difference in overall length of stay in
hospital or in the use of resources following the procedures.
The point estimate of the ICER suggested that open man-
agement dominated arthroscopic management (i.e. arthro-
scopic management was more costly and less effective).
However, due to wide CIs in the differences in cost and
effect, there was a high level of uncertainty about which
treatment was most cost-effective. This further supports the
conclusion that no significant difference between arthro-
scopic and open management was observed.
Take home message: 
The results of this study suggest there is no significant differ-
ence between arthroscopic and open management of full-
thickness rotator cuff tears in terms of the use and cost of resources and
health-related quality of life outcomes in the context of the United King-
dom NHS, based on the findings of the UKUFF trial.
Supplementary material
Tables and figures showing the results using a per-
protocol approach can be found alongside the online
version of this article at http://www.bjj.boneandjoint.org.uk
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